Health Bulletin: Personalised NeoVax Vaccine in Early Ovarian Cancer Trial News October 16, 2026 Today’s health bulletin: a phase 1 trial found NeoVax, a vaccine personalised from tumour mutations, could be given with nivolumab in recurrent ovarian cancer.
